Licensed alternatives for weight management, including semaglutide (Wegovy) and liraglutide (Saxenda), are available through regulated NHS and private pathways following NICE appraisal
Current administration of the GLP-1RAs is predominantly parenteral, but with the progress in the development of oral formulations [Reference Saxena, Frias and Brown4], their increased use in children and adolescents, unsupervised and/or medically supervised, is inevitable
M.OscarssonJ.StumvollM.JermutusL.et al (2021)
This special soap will eliminate any discolouration and give your skin a healthy glow
Oral cobalamin for pernicious anemia
Clinical studies We split this section between studies of GLP-1RAs in people with mood disorders and studies of mood symptoms in patients with other medical conditions taking GLP-1RAs (Tables 4 and 5, and Extended Data Tables 5 and 6)